Bilgilendirme: Kurulum ve veri kapsamındaki çalışmalar devam etmektedir. Göstereceğiniz anlayış için teşekkür ederiz.

Publication:
Comparative Effectiveness of Switching to Natalizumab or Fingolimod After Relapse on First-Line Relapsing-Remitting Multiple Sclerosis Therapy: Propensity Score Matching Analysis From the MSBase Registry

Research Projects

Organizational Units

Journal Issue

Abstract

Description

34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) -- OCT 10-12, 2018 -- Berlin, GERMANY

Keywords

Citation

WoS Q

Scopus Q

Source

Volume

24

Issue

Start Page

25

End Page

26

Endorsement

Review

Supplemented By

Referenced By